Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA009803-02
Application #
2123208
Study Section
Special Emphasis Panel (SRCD (52))
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
1996-08-01
Budget End
1997-07-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost

  Institution

Name
Yale University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520

  Publications

Edelman, E Jennifer; Dinh, An T; Moore, Brent A et al. (2012) Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians. J Addict Med 6:159-65
Schackman, Bruce R; Leff, Jared A; Polsky, Daniel et al. (2012) Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. J Gen Intern Med 27:669-76
Sullivan, Lynn E; Botsko, Michael; Cunningham, Chinazo O et al. (2011) The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone. J Acquir Immune Defic Syndr 56 Suppl 1:S54-61
Sullivan, Lynn E; Moore, Brent A; O'Connor, Patrick G et al. (2010) The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence. Am J Addict 19:53-8
Barry, Declan T; Irwin, Kevin S; Jones, Emlyn S et al. (2010) Opioids, chronic pain, and addiction in primary care. J Pain 11:1442-50
Wang, Emily A; Moore, Brent A; Sullivan, Lynn E et al. (2010) Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone. J Gen Intern Med 25:670-4
Jones, Emlyn S; Moore, Brent A; Sindelar, Jody L et al. (2009) Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend 99:132-40
Barry, Declan T; Irwin, Kevin S; Jones, Emlyn S et al. (2009) Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med 24:218-25
Sullivan, Lynn E; Moore, Brent A; Chawarski, Marek C et al. (2008) Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors. J Subst Abuse Treat 35:87-92
Fiellin, David A; Moore, Brent A; Sullivan, Lynn E et al. (2008) Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years. Am J Addict 17:116-20

Showing the most recent 10 out of 19 publications